Genus plc (LON:GNS)‘s stock had its “hold” rating restated by equities researchers at Liberum Capital in a research report issued to clients and investors on Monday. They presently have a GBX 2,100 ($27.61) price target on the stock. Liberum Capital’s price target would indicate a potential downside of 4.59% from the stock’s current price.
GNS has been the subject of a number of other research reports. Peel Hunt restated a “buy” rating and issued a GBX 2,600 ($34.18) target price on shares of Genus plc in a research note on Monday, September 4th. Numis Securities Ltd restated a “hold” rating and issued a GBX 1,815 ($23.86) target price on shares of Genus plc in a research note on Thursday, September 7th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of GBX 2,171.67 ($28.55).
Shares of Genus plc (GNS) opened at 2201.00 on Monday. The company has a 50 day moving average price of GBX 1,992.73 and a 200 day moving average price of GBX 1,844.98. The company’s market cap is GBX 1.34 billion. Genus plc has a one year low of GBX 1,652.00 and a one year high of GBX 2,255.28.
About Genus plc
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.